| [1] |
Luo HY, Li TJ. Odontogenic tumors：a study of 1309 cases in a Chinese population[J]. Oral Oncol，2009，45(8):706-711.
|
| [2] |
Morgan PR. Odontogenic tumors：a review[J]. Periodontol 2000，2011,57(1):160-176.
|
| [3] |
Sampson DE, Pogrel MA. Management of mandibular ameloblastoma：the clinical basis for a treatment algorithm[J]. J Oral Maxillofac Surg，1999，57(9):1074-1077,discussion 1078-1079.
|
| [4] |
Hemann MT, Bric A, Teruya-Feldstein J，et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants[J]. Nature，2005，436(7052):807-811.
|
| [5] |
Shachaf CM, Felsher DW. Tumor dormancy and MYC inactivation：pushing cancer to the brink of normalcy[J]. Cancer Res，2005，65(11):4471-4474.
|
| [6] |
李自娟，钟鸣，王洁，等. c-myc mRNA在成釉细胞瘤中的表达[J].上海口腔医学，2004，13(6):515-518.
|
| [7] |
Zhang B, Zhang J, Huang HZ，et al. Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma[J]. J Oral Pathol Med，2010，39(3):219-222.
|
| [8] |
Tekkesin MS, Mutlu S, Olgac V. The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts，radicular cysts，and ameloblastomas[J]. Head Neck Pathol，2011，5(3):248-253.
|
| [9] |
Kumamoto H, Yamauchi K, Yoshida M，et al. Immunohistochemical detection of matrix metalloproteinases（MMPs）and tissue inhibitors of metalloproteinases（TIMPs）in ameloblastomas[J]. J Oral Pathol Med，2003，32(2):114-120.
|
| [10] |
Tao Q, Lv B, Qiao B，et al. Immortalization of ameloblastoma cells via reactivation of telomerase function：Phenotypic and molecular characteristics[J]. Oral Oncol，2009，45(12):e239-e244.
|
| [11] |
Barsyte-Lovejoy D, Mao DY, Penn LZ. c-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism[J]. Oncogene，2004，23(19):3481-3486.
|
| [12] |
Fernandez PC, Frank SR, Wang L，et al. Genomic targets of the human c-Myc protein[J]. Genes Dev，2003，17(9):1115-1129.
|
| [13] |
Dews M, Homayouni A, Yu D，et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster[J]. Nat Genet，2006，38(9):1060-1065.
|
| [14] |
Mizukami Y, Fujiki K, Duerr EM，et al. Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc[J]. J Biol Chem，2006，281(20):13957-13963.
|
| [15] |
Gomez-Roman N, Grandori C, Eisenman RN，et al. Direct activation of RNA polymeraseⅢ transcription by c-Myc[J]. Nature，2003，421(6920):290-294.
|
| [16] |
Haggerty TJ, Zeller KI, Osthus RC，et al. A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites[J]. Proc Natl Acad Sci U S A，2003，100(9):5313-5318.
|
| [17] |
de Alborán IM, Baena E, Martinez-A C. c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death[J]. Cell Death Differ，2004，11(1):61-68.
|
| [18] |
Soucie EL, Annis MG, Sedivy J，et al. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria[J]. Mol Cell Biol，2001，21(14):4725-4736.
|
| [19] |
Bhandari DR, Seo KW, Jung JW，et al. The regulatory role of c-MYC on HDAC2 and PcG expression in human multipotent stem cells[J]. J Cell Mol Med，2011，15(7):1603-1614.
|
| [20] |
Kaur S, Soto-Pantoja DR, Stein EV，et al. Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors[J]. Sci Rep，2013(3)1673.
|
| [21] |
Dang CV. c-Myc target genes involved in cell growth，apoptosis，and metabolism[J]. Mol Cell Biol，1999，19(1):1-11.
|
| [22] |
He C, Jiang H, Geng S，et al. Expression of c-Myc and Fas correlates with perineural invasion of pancreatic cancer[J]. Int J Clin Exp Pathol，2012，5(4):339-346.
|
| [23] |
Han G, Wang Y, Bi W. C-Myc overexpression promotes osteosarcoma cell invasion via activation of MEK-ERK pathway[J]. Oncol Res，2012，20(4):149-156.
|
| [24] |
Li ZR, Wu YF, Ma CY，et al. Down-regulation of c-Myc expression inhibits the invasion of bile duct carcinoma cells[J]. Cell Biol Int，2011，35(8):799-802.
|
| [25] |
Cho HJ, Oh YJ, Kwon J，et al. c-Myc stimulates cell invasion by inhibiting FBX8 function[J]. Mol Cells，2010，30(4):355-362.
|
| [26] |
Cui J, Dong BW, Liang P，et al. Effect of c-myc，Ki-67，MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection[J]. World J Gastroenterol，2004，10(10):1533-1536.
|
| [27] |
Lu Q, Hong W. Bcl2 enhances c-Myc-mediated MMP-2 expression of vascular smooth muscle cells[J]. Cell Signal，2009，21(7):1054-1059.
|
| [28] |
Hatakeyama S, Watanabe M, Fujii Y，et al. Targeted destruction of c-Myc by an engineered ubiquitin ligase suppresses cell transformation and tumor formation[J]. Cancer Res，2005，65(17):7874-7879.
|
| [29] |
Zhang B, Zhang J, Huang HZ，et al. Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity[J]. J Oral Pathol Med，2009，38(9):731-736.
|